Pair Name | Lentinan, Oxaliplatin | ||
Phytochemical Name | Lentinan (PubChem CID: 37723 ) | ||
Anticancer drug Name | Oxaliplatin (PubChem CID: 9887053 ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | Lentinan, Oxaliplatin | |||
Disease Info | [ICD-11: 2B70] | Esophageal cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
Down-regulation | Expression | BCL2 | hsa596 | |
Up-regulation | Expression | CALR | hsa811 | |
Up-regulation | Cleavage | CASP3 | hsa836 | |
Up-regulation | Expression | HSP90AA1 | hsa3320 | |
Up-regulation | Expression | HSPA1A | hsa3303 | |
In Vitro Model | Eca-109 | Esophageal squamous cell carcinoma | Homo sapiens (Human) | CVCL_6898 |
Result | These data imply that LNT increases the susceptibility of esophageal cancerous cells to Oxa by driving EC-109 cells to display immunogenic death. Therefore, LNT combined with Oxa may be an effective method in esophageal cancer management. |
No. | Title | Href |
---|---|---|
1 | Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death. Comput Math Methods Med. 2023 Oct 4;2023:9827631. doi: 10.1155/2023/9827631. | Click |